Muscat: The Sultanate begins tomorrow, Sunday, the vaccination campaign with the “Pfizer-Biontech” vaccine against the Coronavirus (Covid-19), targeting in the first stage the groups most vulnerable to infection, including frontline workers, people with chronic diseases and the elderly.
It is noteworthy that the “Pfizer-BioNTech” vaccine, produced by the American company Pfizer in cooperation with German BioNTech, is designed to stimulate the body’s immune system to produce antibodies to the Covid-19 virus and fight it safely. It will consist of two doses, separated by 21 days.
The Ministry of Health said that the vaccinations will be for high risk group and that the specialists in the MOH will contact them in advance.
more recommended stories
Oman Launches Workshop to Study Building Materials Sector and Boost CompetitivenessOman Explores Investment Potential in Building.
OCCI Seminar Explores Stronger Links Between Farms and Food Factories in OmanOCCI Hosts ‘From Farm to Factory’.
OCCI Seminar Highlights Growing Role of Freelance Work in Oman’s EconomySeminar Calls for Stronger Support for.
MSX 30 Index Rises 0.45% as Muscat Stock Exchange Extends GainsMSX 30 Index Closes Higher at.
Shura Council Reviews Draft Environmental Law and Alternative Penalties BillMuscat: The Shura Council discussed a.
His Majesty Appoints Board of Directors for International Financial Centre of OmanHis Majesty Appoints Board of Directors.
Oman Inaugurates Histocompatibility Laboratory to Support Organ Transplant ProgrammesOman Achieves Milestone in Organ Transplant.
Oman National Team Concludes Indonesia Camp Ahead of Gulf Cup 27 and Asian Cup 2027Oman National Team Concludes Training Camp.
Oman’s Dawood Al Yousfi Wins Silver at World Taekwondo Junior ChampionshipsOmani Taekwondo Talent Dawood Al Yousfi.
-
University of Technology and Applied Sciences Signs Film Industry Cooperation Agreement
Muscat: The University of Technology and.

